EUVIMEDEUVIMED entdecken
Video/Audio

The Isolation and Characterization of Low- and Normal- Density Neutrophils from Whole Blood

Anjali S Yennemadi, Joseph Keane, Gina Leisching

Journal of Visualized Experiments · 2025

DOI: 10.3791/67805 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2025. Verfasst von Anjali S Yennemadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, St James's Hospital, Trinity College Dublin, The Univ…. Hauptthemen laut MEDLINE: Neutrophils, Cell Separation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsCell SeparationHumansCentrifugation, Density Gradient

Autor:innen und Institutionen

  • TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, St James's Hospital, Trinity College Dublin, The University of Dublin.
  • TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, St James's Hospital, Trinity College Dublin, The University of Dublin; gina.leisching@tcd.ie.

Zitieren

APA

Yennemadi, A. S., Keane, J., & Leisching, G. (2025). The Isolation and Characterization of Low- and Normal- Density Neutrophils from Whole Blood. Journal of Visualized Experiments. https://doi.org/10.3791/67805

Vancouver

Yennemadi AS, Keane J, Leisching G. The Isolation and Characterization of Low- and Normal- Density Neutrophils from Whole Blood. Journal of Visualized Experiments. 2025. doi:10.3791/67805

BibTeX
@article{Yennemadi2025,
  author = {Yennemadi, Anjali S and Keane, Joseph and Leisching, Gina},
  title = {The Isolation and Characterization of Low- and Normal- Density Neutrophils from Whole Blood},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/67805}
}
Kostenlos starten →